Chief Medical Officer (CMO)
Benjamin Zhang, MD
Chief Medical Officer (CMO) of
Yong Ding Biopharm
Dr. Benjamin Zhang is a physician-scientist and translational medicine leader dedicated to advancing next-generation therapies from bench to bedside. As Chief Medical Officer of Yong Ding Biopharm, he drives the company’s clinical and regulatory strategy, ensuring that innovations in cancer diagnostics, immunotherapy, and regenerative medicine are developed with scientific rigor and delivered with patient impact. His expertise spans IND preparation, cell and exosome therapy development, and global clinical trial execution, with a career rooted in bridging academic research and industry application. At Yong Ding Biopharm, Dr. Zhang is focused on shaping a robust medical pipeline that addresses urgent unmet needs and positions the company at the forefront of biotech innovation.
“At Yong Ding Biopharm, my mission is to translate scientific excellence into real-world treatments—bringing hope, access, and better outcomes to patients worldwide.”
Academic Excellence
M.D., School of Medicine, Taipei Medical University (2017–2023)
Comprehensive training in clinical medicine, research methodologies, and patient-centered care.
Professional Achievements
"METHOD FOR THE PRODUCTION OF GAMMA DELTA T CELLS FOR IMMUNOTHERAPY APPLICATIONS", U.S. Patent Application No.: 63/742,633
Published breakthrough research in high-impact journals like Int J Mol Sci, Cancers, and Biochim Biophys Acta.
Overseeing clinical development and regulatory submissions to support the evaluation of safety and efficacy for investigational cancer therapies.
Entrepreneurial Ventures
Yong Ding Biopharm
Advancing the research and development of precision medicine and exosome-based investigational therapies, with a focus on early cancer detection and limbal stem cell exosome therapy.
JY Biomedical
Advancing the research and development of cancer vaccines, cell therapies, and regenerative medicine approaches in collaboration with major partners, including Hexun Biosciences and 3D Global Biotech.
Philanthropy and Leadership
Dr. Zhang is committed to advancing global healthcare and supporting efforts to improve patient outcomes. He actively participates in philanthropic initiatives aimed at expanding access to innovative therapies, with a particular focus on cancer treatment and regenerative medicine.
